KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to $3.7 million.

  • Maxlinear's Capital Expenditures rose 6908.34% to $3.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.6 million, marking a year-over-year decrease of 2874.43%. This contributed to the annual value of $12.6 million for FY2025, which is 2874.43% down from last year.
  • Per Maxlinear's latest filing, its Capital Expenditures stood at $3.7 million for Q4 2025, which was up 6908.34% from $5.7 million recorded in Q3 2025.
  • Over the past 5 years, Maxlinear's Capital Expenditures peaked at $16.6 million during Q4 2022, and registered a low of $1.2 million during Q2 2025.
  • Moreover, its 5-year median value for Capital Expenditures was $5.1 million (2023), whereas its average is $6.2 million.
  • As far as peak fluctuations go, Maxlinear's Capital Expenditures surged by 49439.61% in 2021, and later tumbled by 9233.82% in 2023.
  • Maxlinear's Capital Expenditures (Quarter) stood at $12.2 million in 2021, then soared by 35.83% to $16.6 million in 2022, then plummeted by 92.34% to $1.3 million in 2023, then soared by 72.14% to $2.2 million in 2024, then surged by 69.08% to $3.7 million in 2025.
  • Its Capital Expenditures was $3.7 million in Q4 2025, compared to $5.7 million in Q3 2025 and $1.2 million in Q2 2025.